Cogent Biosciences, Inc. (COGT) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Cogent Biosciences, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -7.30x | -3.17x | -2.43x | -4.84x | -4.60x | -1.66x |
| P/B Ratio | 3.77x | 3.16x | 1.82x | 2.66x | 1.55x | 0.53x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 15.81x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -227.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -1044.3% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -950.4% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -439.2% |
| Liquidity | ||||||
| Current Ratio | 14.23x | 5.32x | 7.09x | 9.87x | 13.04x | 18.70x |
| Quick Ratio | 14.23x | 5.32x | 7.09x | 9.87x | 13.04x | 18.70x |
| Leverage | ||||||
| Debt/Equity | 0.40x | 0.07x | 0.07x | 0.08x | 0.01x | 0.02x |
YoY = year-over-year change. Source: FMP..